10x Genomics, Inc…
USUSD10x Genomics, Inc. (US:TXG) — Biotechnology: Laboratory Analytical Instruments. Количество бирж, на которых торгуются акции компании: 2. На этой странице — цена и график, дивиденды, крупнейшие держатели и история количества акций.
О компании
- Сайт
- 10xgenomics.com
- Сектор
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Штаб-квартира
- Pleasanton, United States
- Генеральный директор
- Dr. Serge Saxonov Ph.D.
- Сотрудники
- 1 178
- Основана
- 2012
- Акций в обращении
- 120.21 млн
- Свободное обращение
- 118.19 млн
- Рыночная капитализация
- 11.53 млрд USD
- Инсайдеры
- 1.46%
- Институциональные инвесторы
- 120.2%
- Отрасль (SIC)
- Laboratory Analytical Instruments
- ISIN
- US88025U1097
- LEI
- 5493003Z6741WNLG7H43
- Коэффициент выплат
- 0%
- FCF
- 121 млн USD
- Долг
- 0 USDденег больше, чем долга
- Стаж дивидендов
- —
- Прибыль, FCF и выплаченные дивиденды — за 12 месяцев до 30.06.2026 (последний отчёт компании).
Описание
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Дивиденды
Выплаты дивидендов не обнаружены (проверено 10.10.2026). Компания, вероятно, не выплачивает дивиденды.
Новости этой недели
Новостей с сайта компании пока нет.
Крупнейшие держатели
| Держатель | Доля | Акции | Дата отчета |
|---|---|---|---|
| FMR, LLC | 14.67% | 17.63 млн | 2026-06-30 |
| Blackrock Inc. | 8.99% | 10.8 млн | 2026-06-30 |
| ARK Investment Managemen… | 8.32% | 10 млн | 2026-06-30 |
| Vanguard Portfolio Manag… | 5.81% | 6.98 млн | 2026-06-30 |
| Quantinno Capital Manage… | 4.55% | 5.47 млн | 2026-06-30 |
| Vanguard Capital Managem… | 4.23% | 5.08 млн | 2026-06-30 |
| Price (T.Rowe) Associate… | 3.78% | 4.54 млн | 2026-06-30 |
| Sumitomo Mitsui Trust Gr… | 3.49% | 4.19 млн | 2026-06-30 |
| Amova Asset Management A… | 3.49% | 4.19 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.94% | 3.53 млн | 2026-06-30 |
| Morgan Stanley | 2.79% | 3.35 млн | 2026-06-30 |
| iShares Trust-iShares Ru… | 2.53% | 3.04 млн | 2026-07-31 |
| ARK ETF Trust-ARK Genomi… | 2.53% | 3.04 млн | 2026-08-31 |
| ARK ETF Trust-ARK Innova… | 2.5% | 3.01 млн | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 2.12% | 2.55 млн | 2026-06-30 |
| Fidelity Select PORT.s-S… | 1.66% | 2 млн | 2026-07-31 |
| Fidelity Rutland Square… | 1.37% | 1.65 млн | 2026-07-31 |
| Fidelity Select Portfoli… | 1.34% | 1.61 млн | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 1.22% | 1.47 млн | 2026-06-30 |
| T. Rowe Price New Horizo… | 1.21% | 1.46 млн | 2026-06-30 |
| SAXONOV SERGE WILSON (Ch… | ≈1.11% | 1.34 млн | 2026-09-22 |
| HINDSON BENJAMIN J (Pres… | ≈0.41% | 488 182 | 2026-08-24 |
| STUELPNAGEL JOHN R (Dire… | ≈0.27% | 328 436 | 2026-09-03 |
| TAICH ADAM (Chief Financ… | ≈0.26% | 316 344 | 2026-09-09 |
| MATEO ALAN V. (Director) | ≈0.07% | 85 877 | 2026-06-04 |
| KOSARAJU SRIDHAR (Direct… | ≈0.06% | 68 278 | 2026-06-04 |
| POPOVITS KIMBERLY J (Dir… | ≈0.03% | 37 445 | 2026-06-04 |
| TEICHMANN SARAH A. (Dire… | ≈0.02% | 28 058 | 2026-08-14 |
| SULIMAN SHEHNAAZ (Direct… | ≈0.02% | 23 792 | 2026-09-22 |
